Next 10 |
home / stock / sttk / sttk articles
Kymera Therapeutics, Inc. (NASDAQ: KYMR) shares ended the last trading session 23.4% higher at $39.44. The jump came on an impressive volume with a...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
- Conference call and webcast to be held June 14, 2024 at 7:30 a.m. ET featuring lead investigator - AUSTIN, TX and DURHAM, NC, June 06, 2024 (G...
AUSTIN, TX & DURHAM, NC, April 01, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology com...
AUSTIN, TX and DURHAM, NC, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology compa...
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guida...
AUSTIN, TX and DURHAM, NC, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology compan...
Shares of Nxu, Inc. (NASDAQ: NXU) rose sharply in pre-market trading after the company signed a letter of intent outlining investment in Lynx Moto...
U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision on Wednesday. The Dow traded up 0.58% ...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Kaixin Holdings (KXIN) rose 171.5% to $0.3421 on volume of 647,176,435 shares iShares China Large-Cap ETF (FXI) rose 7.2% to $35.48 on volume of 213,691,731 shares NVIDIA Corporation (NVDA) rose 1.6% to $118.85 on volume of 208,742,004 ...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 3.7% to $117 on volume of 292,186,152 shares PROSHARES TRUST (SQQQ) rose 4.5% to $7.72 on volume of 213,073,959 shares Mangoceuticals Inc. (MGRX) rose 26.4% to $0.2984 on volume of 201,639,758 shares AgE...
2024-10-01 12:30:06 ET H.C. Wainwright analyst issues NEUTRAL recommendation for STTK on October 1, 2024 10:33AM ET. The previous analyst recommendation was Buy. STTK was trading at $1.9801 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...